Biology subjects

Greig, J.

Publications and source records attributed to Greig, J..

7 recordsLinked to original sources

bioRxiv2026

Clathrin differentially adapts its trimerisation domain during mammalian evolution to traffic the insulin-responsive GLUT4 glucose transporter.

In humans, the CHC22 isoform of clathrin regulates glucose metabolism by trafficking the GLUT4 glucose transporter for intracellular storage in skeletal muscle and release following insulin signalling. Some vertebrate lineages have lost the gene encoding CHC22 but operate the same insulin-stimulated GLUT4 trafficking pathway. Here, we show that species lacking CHC22 exclusively produce an alternatively-spliced form of the universally expressed CHC17 clathrin isoform (CHC17-SAS) with a truncated C-terminus similar to CHC22, expressed predominantly in skeletal muscle. Through its trimerisation domain, CHC17-SAS binds the CHC22-specific adaptor SNX5 that enables CHC22's distinct intracellular function. The 2.3 [A] crystal structure of the CHC22 trimerisation domain demonstrates conservation of the core trimeric fold from CHC17 but differences in electrostatic surface charge that may account for their differential properties. Using GLUT4 translocation assays in HeLa cell models, we show that CHC17-SAS is a functional surrogate for CHC22. Identification of CHC17-SAS resolves the evolutionary conundrum posed by CHC22 absence in some vertebrate lineages, and reveals a common mechanism for mammalian GLUT4 trafficking.

cell biology↗

bioRxiv2026

An Aging Risk-Factor Scale: Biomarkers of Renal Disease and Anemia are Primary Predictors of Three-Year Survival in Common Marmosets (Callithrix jacchus)

Valid animal models are needed to evaluate how age-related changes in kidney function influence healthspan. Aging marmosets frequently develop renal insufficiency with anemia and exhibit reductions in body mass and metabolic rate. However, it remains unclear which age-related changes predict survival and which thresholds indicate increased mortality risk. We prospectively evaluated age, body composition, resting energy expenditure, hematology, and blood chemistry as predictors of 3-year survival in female and male marmosets (n = 66), 2-16 years of age. Objectives were to identify prognostic markers, define high-risk thresholds, and to develop and test a composite risk-factor scale for mortality screening in captivity. A 10-variable model showed the best predictive performance in multivariable Cox proportional hazards modeling, and was retained for further analysis (concordance = 0.881, p < 0.001). ROC curves using Youdens Index and AUC identified high-risk thresholds for predictors in the multivariable model, and threshold-defined categories were evaluated by Kaplan-Meier survival analysis. The 10 binary risk-factors were combined into a composite scale scored from 0 to 10 and tested with Cox regression. The scale explained approximately 42% of variance in survival and each additional risk factor increased mortality risk 1.75-fold (95% CI: 1.43-2.14, p < 0.001). Marmosets with [≥]7 risk factors exhibited a 19-month reduction in survival, and this high-risk threshold predicted 3-year survival with 89.4% accuracy. Results support the scale as a screening tool for mortality risk and highlight the high prevalence of age-associated renal disease and anemia in marmosets.

physiology↗

bioRxiv2026

Metformin enhances differentiation and function of skeletal muscle in models of Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most prevalent inherited muscular dystrophies, for which there are no disease-modifying therapies. Metabolic perturbation, mitochondrial dysfunction, and oxidative stress are key contributors to FSHD pathology. Here, the effects of the metabolic regulator and anti-diabetic drug Metformin on myogenesis and muscle function in human and murine models of FSHD were investigated. Metformin did not affect the proliferation rate of human control or patient-derived FSHD myoblasts but promoted their myogenic differentiation, increasing myotube formation and maturation. Metformin also enhanced the metabolic health and viability of myotubes. Mechanistic interrogation revealed reduced levels of mitochondrial reactive oxygen species and modified mitochondrial turnover. These cellular investigations were complemented with in vivo functional assessment in a murine model of FSHD, in which Metformin treated mice exhibited significantly improved muscle strength. Collectively, these findings identify metabolic regulation as a therapeutically tractable feature of FSHD and demonstrate that Metformin improves muscle function in multiple models of FSHD via reduction of oxidative stress and augmentation of cellular metabolic fitness. These results provide insight into the therapeutic actions of Metformin and pre-clinical data to support its testing for repurposing in FSHD.

cell biology↗

bioRxiv2025

Aging Leads to Altered Physiological Reactivity in Response to Repeated Social Separation Stress in a Nonhuman Primate Model

Social relationships are critical for maintaining physical health and psychological wellbeing. Since nearly 1 in 4 adults aged 65 years or older are socially isolated, there is a strong need to understand how repeated social stress negatively impacts health outcomes. Using a nonhuman primate model of social aging (i.e., marmosets), we examined whether individuals transitioning into old age ("peri-geri") or individuals who were already geriatric ("very-geri") showed differences in measures of hypothalamic-pituitary axis (HPA) activity, markers of metabolic and immune function, and reunion social behavior in response to repeated social separation challenges (SSC). We found female marmosets, especially peri-geri females, had higher HPA reactivity and better HPA recovery than male marmosets, but this difference diminished in older, very-geri marmosets. HPA activity was correlated with multiple outcomes including locomotive behavior and grooming, changes in blood glucose levels, and neutrophil counts. Moreover, marmosets who approached their partner more and were groomed less during reunions had higher cortisol levels the following day. Interestingly, we found two distinct HPA profiles among our marmosets with half showing strong HPA responses (reactors) and the other half showing little or no HPA response (non-reactors). Non-reactors had less weight gain/more weight loss; elevated levels of calcium, phosphorus, and white blood cells; and received less grooming and social contact time during reunion. Overall, old-aged marmosets who show attenuated HPA responses may have different vulnerabilities to negative health and behavioral outcomes during social stress, and male marmosets appear more likely to present with this HPA non-reactor phenotype earlier in aging.

physiology↗

bioRxiv2022

CHC22 clathrin membrane recruitment uses SNX5 in bipartite interaction with secretory tether p115

The two clathrin isoforms, CHC17 and CHC22, mediate separate intracellular transport routes. CHC17 performs endocytosis and housekeeping membrane traffic in all cells. CHC22, expressed most highly in skeletal muscle, transports the glucose transporter GLUT4 from the endoplasmic-reticulum-to-Golgi intermediate compartment (ERGIC) directly to an intracellular GLUT4 storage compartment (GSC) from where GLUT4 can be mobilized to the plasma membrane by insulin. Here, the molecular determinants distinguishing CHC22 from CHC17 trafficking are defined. The C-terminal trimerization domain of CHC22 binds SNX5, which also binds the ERGIC tether p115. SNX5, and the functionally redundant SNX6, are required for CHC22 localization independently of their participation in the endosomal ESCPE-1 complex. In tandem, an isoform-specific patch in the CHC22 N-terminal domain separately mediates binding to p115. This dual mode of clathrin recruitment, involving interactions at both heavy chain termini, is required for CHC22 targeting to ERGIC membranes to mediate the Golgi bypass route for GLUT4 traffic. Interference with either interaction inhibits GLUT4 targeting to the GSC, defining a bipartite mechanism regulating a key pathway in human glucose metabolism.

cell biology↗

bioRxiv2019

Interplay between cortical actin and E-cadherin dynamics regulates cell shape in the Drosophila embryonic epidermis

Precise regulation of cell shape is vital for building functional tissues. Here, we study the mechanisms which lead to the formation of highly elongated anisotropic epithelial cells in the Drosophila epidermis. We demonstrate that this cell shape is the result of two counteracting mechanisms at the cell surface: actomyosin, which inhibits cell elongation downstream of RhoA signalling, and intercellular adhesion, modulated via clathrin-mediated endocytosis of E-cadherin, which promotes cell elongation downstream of the GTPase Arf1. We show that these two mechanisms are interconnected, with RhoA signalling activity reducing Arf1 recruitment to the plasma membrane. Additionally, cell adhesion itself regulates both mechanisms: p120-catenin, a regulator of intercellular adhesion, promotes the activity of both Arf1 and RhoA. Altogether, we uncover a complex network of interactions between cell-cell adhesion, the endocytic machinery, and the actomyosin cortex, and demonstrate how this network regulates cell shape in an epithelial tissue in vivo.

developmental biology↗

bioRxiv2018

E-cadherin endocytosis is modulated by p120-catenin through the opposing actions of RhoA and Arf1

The regulation of E-cadherin at the plasma membrane by endocytosis is of vital importance for developmental and disease. p120-catenin, which binds to the E-cadherin C-terminus, can both promote and inhibit E-cadherin endocytosis. However, little is known about what determines the directionality of p120-catenin activity, and the molecules downstream. Here, we have discovered that p120-catenin fine-tunes the clathrin-mediated endocytosis of E-cadherin in Drosophila embryonic epidermal cells. It simultaneously activated two actin-remodelling pathways with opposing effects: RhoA, which stabilized E-cadherin at the membrane, and Arf1, which promoted internalization. Epistasis experiments revealed that RhoA additionally inhibited Arf1. E-cadherin was efficiently endocytosed only in the presence of intermediate p120-catenin amounts with too little and too much p120-catenin inhibiting E-cadherin endocytosis. Finally, we found that p120-catenin levels altered the tension of the plasma membrane. Altogether, this shows that p120-catenin is a central hub which co-ordinates cell adhesion, endocytosis, and actin dynamics with tissue tension.

cell biology↗